Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Glass, Leslie L"'
Publikováno v:
British Journal of Pharmacology. Mar2016, Vol. 173 Issue 5, p888-898. 11p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Glass, Leslie L., Calero-Nieto, Fernando J., Jawaid, Wajid, Larraufie, Pierre, Kay, Richard G., Göttgens, Berthold, Reimann, Frank, Gribble, Fiona M.
Publikováno v:
In Molecular Metabolism October 2017 6(10):1296-1303
Autor:
Brighton, Cheryl A, Rievaj, Juraj, Kuhre, Rune E, Glass, Leslie L, Schoonjans, Kristina, Holst, Jens J, Gribble, Fiona M, Reimann, Frank
Publikováno v:
Endocrinology
Bile acids are well-recognized stimuli of glucagon-like peptide-1 (GLP-1) secretion. This action has been attributed to activation of the G protein-coupled bile acid receptor GPBAR1 (TGR5), although other potential bile acid sensors include the nucle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fccf11aedde73d70dec645679854d006
http://europepmc.org/articles/PMC4606749
http://europepmc.org/articles/PMC4606749
Autor:
Larraufie, Pierre, Kay, Richard G., Galvin, Sam G., Miedzybrodzka, Emily L., Glass, Leslie L., Ma, Marcella K. L., Lam, Brian, Yeo, Giles S. H., Chiarugi, Davide, Reimann, Frank, Gribble, Fiona M., Roberts, Geoffrey P., Richards, Paul, Hardwick, Richard H., Scharfmann, Raphaël, Leiter, Andrew, Li, H. Joyce
Publikováno v:
Diabetes; May2019, Vol. 68 Issue 5, p1062-1072, 11p, 5 Graphs
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hodge D; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, WT-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK., Glass LL; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, WT-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK., Diakogiannaki E; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, WT-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK., Pais R; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, WT-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK., Lenaghan C; AstraZeneca, Cardiovascular & Metabolic Diseases iMed, Alderley Park, Cheshire, UK., Smith DM; AstraZeneca, Cardiovascular & Metabolic Diseases iMed, Mölndal, Sweden., Wedin M; AstraZeneca, Transgenics Group, Reagents & Assay Development, Discovery Sciences, Mölndal, Sweden., Bohlooly-Y M; AstraZeneca, Transgenics Group, Reagents & Assay Development, Discovery Sciences, Mölndal, Sweden., Gribble FM; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, WT-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK. Electronic address: fmg23@cam.ac.uk., Reimann F; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, WT-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK. Electronic address: fr222@cam.ac.uk.
Publikováno v:
Peptides [Peptides] 2016 Mar; Vol. 77, pp. 16-20. Date of Electronic Publication: 2015 Jul 02.